Can these drugs block eye Cancer's spread?
NCT ID NCT02068586
First seen Mar 22, 2026 · Last updated May 16, 2026 · Updated 7 times
Summary
This study tests two drugs, sunitinib and valproic acid, to see if they can prevent high-risk uveal melanoma (a type of eye cancer) from spreading to other parts of the body. About 210 people who have already had their eye tumor treated are taking one of these drugs for up to a year. The goal is to see if either drug improves survival or delays the cancer coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRIS MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.